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Abstract 
Introduction: Various methods have been used to sample biliary strictures 
including percutaneous fine-needle aspiration biopsy, intraluminal biliary 
washings and cytological analysis of drained bile. However, none of these 
methods have proven to be particularly sensitive in the diagnosis of biliary tract 
malignancy. We report improved diagnostic accuracy using a modified technique 
at percutaneous transluminal biopsy in these patients. 
Materials and Methods: 52 patients with obstructive jaundice due to a 
biliary stricture underwent transluminal forceps biopsy using flexible biopsy 
forceps kit commonly used for cardiac biopsies using a modified ‘cross and push’ 
technique. This entailed crossing the stricture with a 0.038-inch wire leading all 
the way down into the duodenum. A standard or long sheath was subsequently 
advanced up to the stricture over the wire. A Cook 5.2Fr biopsy forceps 
alongside the wire was introduced and the cup opened on exiting the sheath. 
With the biopsy forceps open, within the stricture, the sheath was used as a 
pusher to advance biopsy cup into the stricture before the cup was closed and 
sample obtained. The data was analysed retrospectively. 
Results: We report outcomes using this technique on 52 consecutive 
patients with obstructive jaundice secondary to a biliary stricture. The sensitivity 
and accuracy were 93.3% and 94.2% respectively. There was one procedure 
related late complication. 
Conclusion: We propose the modified ‘cross and push’ technique to be a 
feasible, safe and a more accurate option over the standard technique for 
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sampling strictures of the biliary tree.  
Introduction: 
Ultrasound (US) guided fine needle aspiration (FNA) biopsies [1, 2] and 
automated biopsy gun samples [3] have yielded improved sensitivity and 
specificity for several sites in the body except the biliary tree. Sampling the biliary 
tree in suspected malignant obstruction has historically proven problematic and is 
thought to be for two main reasons. Firstly, the tumours are often small and 
visualisation as a biopsy target by ultrasound is technically difficult or impossible 
[4]. Secondly, these tumours are often accompanied by a significant 
desmoplastic response making any sort of sampling unreliable [5-7].  
Endoluminal techniques employed for obtaining biliary samples can be 
broadly divided into those that require a percutaneous or endoscopic access 
tract. Percutaneous based methods include percutaneous transhepatic 
cholangiogram (PTC) brush cytology and cholangioscopy [8] whereas 
endoscopic based methods include endoscopic retrograde cholangio-
pancreatography (ERCP) and endoscopic ultrasound (EUS).   
Whilst EUS-FNA in recent years has become an established method for 
pancreatic lesions with sensitivities approaching 100%, it is less sensitive (79%) 
for hilar strictures [9, 10]. On obtaining access to the biliary tree in either ERCP 
and PTC based methods either washings or brushings can be taken and sent for 
cytology. Brush cytology has been popular and probably the most used method 
despite its low yield of specimen and variable accuracy, with studies showing 
sensitivities ranging from 30 – 75% [11-13].  
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Since the 1980’s biopsy forceps have been used via the percutaneous 
tract to sample the biliary tree and obtain histology in suspected malignant 
obstruction as reported by a few centres [14]. Two smaller studies with less than 
25 patients, showed a wide range of sensitivity as low as 30% [15] and  up to 
100% [16]. Jung et al reported the only large study comprising 130 patients 
where they employed a specific type of forceps (Cordis, Miami, Florida) to obtain 
biopsy samples demonstrating a sensitivity of 78.4% [17]. Tapping et al reported 
cytological sampling versus forceps biopsy during percutaneous transhepatic 
biliary drainage in 119 patients with suspected malignant inoperable obstructive 
jaundice. Histological diagnosis after forceps biopsy was more successful than 
cytology: Sensitivity was 78 versus 61%, and negative predictive value was 30 
versus 19%. Cytology results were never positive when the forceps biopsy was 
negative [18].  
We evaluated our results based on a modified biopsy technique to sample 
biliary strictures in patients with suspected malignant biliary obstruction. 
Materials and Methods: 
We have retrospectively reviewed 52 consecutive patients who had a 
biliary stricture biopsy performed by a single hepatobiliary interventional 
radiologist between Oct. 2007 and March 2012 at a major hepatobiliary centre, 
using the ‘cross and push’ technique. The decision for PTC ± drainage was made 
for all of these patients presenting with obstructive jaundice suspected secondary 
to a malignant obstruction, following approval at a multi-disciplinary team review 
at our institution. This study reports sensitivity, specificity and accuracy of this 
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method of biliary sampling as well as a record of any complications encountered 
during or after the procedure as a result of the biopsy.  
Technique: 
All procedures were performed under intra-venous sedo-analgesia and 
local anaesthesia at the puncture site. Initial percutaneous access to the biliary 
system was achieved with a 21-guage access system (AccuStick™ Boston 
Scientific, MA) followed by an exchange of this access to a 0.038-inch system in 
conventional fashion under ultrasound and fluoroscopic guidance. A 
cholangiogram to identify the level of obstruction was performed and access to 
the biliary tree secured using a standard (11cm length) 7 Fr Brite-tip sheath 
(Cordis™, Miami, FL) or a long (23cm length) 7 Fr sheath (Cordis™, Miami, FL). 
Thereafter attempts were made to cross the biliary stricture using standard 
interventional radiology techniques with a variety of catheters and wires. It is 
imperative to cross the stricture with a 0.038-inch wire leading all the way down 
into the duodenum. The sheath is then advanced over the wire up to the proximal 
limit of the stricture. A flexible cup biopsy forceps (Cook 5.2 Fr 60cm myocardial 
biopsy forceps with a standard sized (2.25cc) cup (Cook™, Bloomington, IN)) 
was then passed through the sheath alongside the guide wire. The cup was 
opened on exiting the sheath with the tip of the sheath remaining resident just 
proximal to the stricture. With the biopsy forceps open in this manner, within the 
stricture, we then used the sheath as a pusher to advance the open biopsy 
forceps into the stricture before the cup was closed and sample obtained (Fig. 
1a). Up to five samples were taken and sent for histology. The sheath always 
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remained in-situ to allow safe exchange of the biopsy forceps between each 
samples. The procedure was completed with a control cholangiogram following 
placement of a biliary drain or a metallic stent in a conventional manner.  
The modified ‘cross and push technique’ was employed in 52 patients. 
Data was collected retrospectively recording age, sex, pre-biopsy liver functions, 
biopsy characteristics, location and histology of lesion. The data is presented 
including results of final diagnosis and complications. Probability of survival was 
determined using the Kaplan-Meier method. Correlation of biopsy results to final 
diagnosis was established either through subsequent follow-up (both radiological 
and clinical) or surgical histology. 2 X 2 table statistics were performed to derive 
sensitivity, specificity, positive (PPV) and negative (NPV) predictive value; and 
accuracy.  
Results: 
52 patients who presented with obstructive jaundice presumed secondary 
to a suspected malignant stricture in the biliary tree based on clinical 
presentation and findings at PTC cholangiogram were included in the study. The 
results are presented in Table 1. All biopsies had samples reliable to make a 
histologic diagnosis. None of the samples obtained were found to be suspicious, 
inadequate, necrotic or with fibrinous materials. There were 4 (8%) crush 
artefacts but despite this the cyto-pathological assessment was possible as the 
largest dimension amongst these samples was 1-2 mm. 42 of the fifty-two (81%) 
biopsies resulted in a correct diagnosis of malignancy. The specific histologic 
diagnosis correlated with the clinical diagnosis in 49 cases (accuracy - 94.2%). 
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The remaining three cases were confirmed to have an underlying malignancy 
(false negatives), although the exact histologic type was on PTC biopsy was 
reported as benign (inflammatory changes). One of these three patients had 
strictures secondary to a primary gall-bladder carcinoma and the other two had 
primary gastric and colo-rectal cancers each, causing extrinsic compression of 
the biliary tree from lymph node secondaries. There were seven true negative 
diagnoses. There were no false-positive diagnoses. For the diagnosis of 
malignant biliary obstruction, transluminal forceps biopsy using ‘cross and push’ 
technique had a sensitivity of 93.3% and a specificity of 100%. Although the 
positive predictive value was 100%, the negative predictive value was only 70%. 
Median overall survival in patients with malignant biliary strictures following 
primary decompression and histology was 4.8 months.  
We noticed one procedure related complication. The patient presented 
with haemobila two months post procedure. CT showed a hepatic artery 
pseudoaneurysm located in the periphery of the liver at the access point from the 
PTC. This was anatomically distant from the biopsy site, which was at the distal 
CBD. It was treated successfully with embolisation. 
Discussion: 
We report an accurate and safe ‘technical note’ to sample the biliary tree 
in suspected malignant obstruction using readily available kit. 
We favoured the 5.2 Fr flexible biopsy forceps and used it for all patients 
as it permitted its deployment alongside a guide wire within the sheath. We 
recommended biopsy forceps to be advanced inside a long 7 Fr sheath with the 
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tip placed in the stricture (Fig 2a, b). This is possible alongside a 0.038-inch wire 
after the stricture has been crossed. It seems logical that the leading edge of the 
sheath can aid pushing an open cup of the biopsy forceps into the substance of 
the stricture (Fig 1a) thereby resulting in better sampling. We believe retro-flexion 
(Fig 1b) of the biopsy cups results in a poor tissue yield and could be prevented 
by deploying the ‘cross and push’ technique.  
The procedure related complication (hepatic pseudoaneurysm) was due to 
the PTC access and not the biopsy as it was anatomically distant. Such 
complications are well reported in patients who have a PTC alone, hence we 
believe it is not solely due to the biopsy technique [20]. 
 We recognise differentiating true from false negatives is difficult. Overall 
there were 10 patients with a negative biopsy for malignancy of which 3 (5.7%) 
were regarded as false negatives. This was on the basis of clinical and 
radiological corroboration during subsequent follow-up and histocytopathological 
evidence where available. The overall limitations of the modified technique lie in 
the low negative predictive value of 70%. However, given the nature of the 
disease process and desmoplastic response associated with cholangiocarcinoma 
a higher false negative rate may be expected. Extrinsic compression of biliary 
tree, which is usually extrahepatic, is generally managed by ERCP and stenting 
at our institution and hence we had only 2 patients.  In both cases the 
percutaneous endoluminal biopsy (PTEB) histology obtained was benign. We 
also recognise such patients are more prone to get a false negative result and 
hence the biopsy results are unreliable in extrinsic lesions [21]. We also noticed 
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some crush artefacts but achieved decent quality histology in spite of small cup 
size. We believe our modified technique is more sensitive with better accuracy 
than FNA biopsy [22], bile cytology [23], brush cytology [11-13] and previously 
described forceps biopsy techniques [8, 18] for sampling the biliary tree in 
obstructive jaundice.  Patients often present with severe liver dysfunction and the 
referring institution usually achieves drainage of the biliary tree. We believe a 
rapid diagnosis is imperative in patients suspected with malignant strictures, as 
overall survival is poor.  
The overall sensitivity of the techniques reported here was comparable 
with the largest reported study employing intra-luminal forceps biopsies to 
sample the biliary tree [17]. However our modified technique yielded better 
sensitivity and accuracy of sampling suspected malignant biliary strictures. The 
reluctance to pursue a histological confirmation in all cases is understandable. 
NCCN guidelines do recommend biopsy in certain situations [19]. However, we 
are in favour of a biopsy whenever possible in patients presenting with suspected 
malignant biliary obstruction based on clinical, imaging and laboratory criteria for 
the following reasons. Firstly, we have found a 13.5% incidence of true negative 
in cases presumed to be malignant (Table 1). Secondly, 8% cases had 
unexpected malignant histology such as NET, HCC and CRM which had an 
entirely different course of therapy. Finally, histological confirmation may be 
required to enrol patients in appropriate clinical trials. Hence we recommend that 
this modified technique be employed in all cases where PTC is undertaken for 
suspected bile duct malignancy.
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n 52 
          
      Mean Age in years (95%CI) 68.8 (+/-3) 
      Age range (years) 38.2 – 87.8 
      Male: Female ratio 1.9:1 
          
      Mean Pre-Biopsy liver functions (95%CI)   
      Bilirubin (umol/L) 284 (+/-50) 
      GGT (IU/L) 330 (+/-91) 
      AST (IU/L) 119 (+/-25) 
      ALT (IU/L) 119 (+/-28) 
      ALP (IU/L) 1562 (+/-326) 
          
      Biopsy characteristics   
      Median number of Cores 3 
      Median length of cores (mm) 2 
      Crush artefacts 4/52 (8%) 
          
      Histology and Location of stricture   Intra-hepatic Extra-hepatic 
Benign Histology on PTEB (True 
negatives) n = 7 Hilar 
Main 
RHD 
Distal 
CBD 
Mid 
CBD 
Proximal 
CBD BEA 
Benign (all inflammatory) 7 1   3 1 1 1 
Benign Histology on PTEB (False 
negatives) n = 3             
Solitary metastasis from previously resected 
gastric adenocarcinoma 1     1       
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Solitary metastasis from previously resected 
gall bladder adenocarcinoma 1 1           
de novo Colorectal Metastasis (CRM) 1 1           
      
Malignant Histology on PTEB n = 42 Hilar Main RHD 
Distal 
CBD 
Mid 
CBD 
Proximal 
CBD BEA 
Cholangiocarcinoma 28 17 1 5 1 4  
Pancreatic Adenocarcinoma 11 2   9      
Hepatocelluar Carcinoma (HCC) 1 1          
Neuroendocrine Tumour (NET) 2 2          
    
     Test reliability to pick up malignant biliary 
strictures   
     Sensitivity (%) 93.3 
     Specificity (%) 100 
     Positive Predictive Value (%) 100 
     Negative Predictive Value (%) 70 
     Accuracy (%) 94.2 
         
      
Procedure related complication 
1 (Hepatic 
artery pseudo-
aneurysm 
      Median Follow up (months)  8.5 
      Median Overall Survival (months) since 
biopsy with benign histology  31.0 
      Median Overall Survival (months) since 
biopsy with malignant histology  6.8 
      
11  
Table 1: Patient characteristics and overall data. 
(* False Negatives; RHD – Right hepatic duct; CBD – Common Bile Duct; BEA – Biliary Enteric Anastomosis)
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